180 related articles for article (PubMed ID: 11854353)
1. The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome.
Schultz ES; Chapiro J; Lurquin C; Claverol S; Burlet-Schiltz O; Warnier G; Russo V; Morel S; Lévy F; Boon T; Van den Eynde BJ; van der Bruggen P
J Exp Med; 2002 Feb; 195(4):391-9. PubMed ID: 11854353
[TBL] [Abstract][Full Text] [Related]
2. A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy.
Ma W; Vigneron N; Chapiro J; Stroobant V; Germeau C; Boon T; Coulie PG; Van den Eynde BJ
Int J Cancer; 2011 Nov; 129(10):2427-34. PubMed ID: 21207413
[TBL] [Abstract][Full Text] [Related]
3. A new tumor-specific antigen encoded by MAGE-C2 and presented to cytolytic T lymphocytes by HLA-B44.
Godelaine D; Carrasco J; Brasseur F; Neyns B; Thielemans K; Boon T; Van Pel A
Cancer Immunol Immunother; 2007 Jun; 56(6):753-9. PubMed ID: 17096150
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the processing of seven human tumor antigens by intermediate proteasomes.
Guillaume B; Stroobant V; Bousquet-Dubouch MP; Colau D; Chapiro J; Parmentier N; Dalet A; Van den Eynde BJ
J Immunol; 2012 Oct; 189(7):3538-47. PubMed ID: 22925930
[TBL] [Abstract][Full Text] [Related]
5. A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells.
Ottaviani S; Zhang Y; Boon T; van der Bruggen P
Cancer Immunol Immunother; 2005 Dec; 54(12):1214-20. PubMed ID: 16025263
[TBL] [Abstract][Full Text] [Related]
6. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis GR; Boon T; van der Bruggen P
J Immunol; 1999 Sep; 163(5):2928-36. PubMed ID: 10453041
[TBL] [Abstract][Full Text] [Related]
7. Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses.
Breckpot K; Heirman C; De Greef C; van der Bruggen P; Thielemans K
J Immunol; 2004 Feb; 172(4):2232-7. PubMed ID: 14764691
[TBL] [Abstract][Full Text] [Related]
8. A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes.
Duffour MT; Chaux P; Lurquin C; Cornelis G; Boon T; van der Bruggen P
Eur J Immunol; 1999 Oct; 29(10):3329-37. PubMed ID: 10540345
[TBL] [Abstract][Full Text] [Related]
9. Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.
Ayyoub M; Stevanovic S; Sahin U; Guillaume P; Servis C; Rimoldi D; Valmori D; Romero P; Cerottini JC; Rammensee HG; Pfreundschuh M; Speiser D; Lévy F
J Immunol; 2002 Feb; 168(4):1717-22. PubMed ID: 11823502
[TBL] [Abstract][Full Text] [Related]
10. A new MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A24 carcinoma cells.
Ottaviani S; Colau D; van der Bruggen P; van der Bruggen P
Cancer Immunol Immunother; 2006 Jul; 55(7):867-72. PubMed ID: 16151806
[TBL] [Abstract][Full Text] [Related]
11. The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses.
Sartorius R; Pisu P; D'Apice L; Pizzella L; Romano C; Cortese G; Giorgini A; Santoni A; Velotti F; De Berardinis P
J Immunol; 2008 Mar; 180(6):3719-28. PubMed ID: 18322177
[TBL] [Abstract][Full Text] [Related]
12. An antigenic peptide produced by peptide splicing in the proteasome.
Vigneron N; Stroobant V; Chapiro J; Ooms A; Degiovanni G; Morel S; van der Bruggen P; Boon T; Van den Eynde BJ
Science; 2004 Apr; 304(5670):587-90. PubMed ID: 15001714
[TBL] [Abstract][Full Text] [Related]
13. Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma.
Huang LQ; Brasseur F; Serrano A; De Plaen E; van der Bruggen P; Boon T; Van Pel A
J Immunol; 1999 Jun; 162(11):6849-54. PubMed ID: 10352307
[TBL] [Abstract][Full Text] [Related]
14. A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes.
Schultz ES; Zhang Y; Knowles R; Tine J; Traversari C; Boon T; van der Bruggen P
Tissue Antigens; 2001 Feb; 57(2):103-9. PubMed ID: 11260504
[TBL] [Abstract][Full Text] [Related]
15. Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome.
Van den Eynde BJ; Morel S
Curr Opin Immunol; 2001 Apr; 13(2):147-53. PubMed ID: 11228406
[TBL] [Abstract][Full Text] [Related]
16. A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes.
Zhang Y; Stroobant V; Russo V; Boon T; van der Bruggen P
Tissue Antigens; 2002 Nov; 60(5):365-71. PubMed ID: 12492812
[TBL] [Abstract][Full Text] [Related]
17. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
Valmori D; Gileadi U; Servis C; Dunbar PR; Cerottini JC; Romero P; Cerundolo V; Lévy F
J Exp Med; 1999 Mar; 189(6):895-906. PubMed ID: 10075973
[TBL] [Abstract][Full Text] [Related]
18. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.
Morel S; Lévy F; Burlet-Schiltz O; Brasseur F; Probst-Kepper M; Peitrequin AL; Monsarrat B; Van Velthoven R; Cerottini JC; Boon T; Gairin JE; Van den Eynde BJ
Immunity; 2000 Jan; 12(1):107-17. PubMed ID: 10661410
[TBL] [Abstract][Full Text] [Related]
19. Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors.
Corbière V; Nicolay H; Russo V; Stroobant V; Brichard V; Boon T; van der Bruggen P
Tissue Antigens; 2004 May; 63(5):453-7. PubMed ID: 15104676
[TBL] [Abstract][Full Text] [Related]
20. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.
Sijts AJ; Ruppert T; Rehermann B; Schmidt M; Koszinowski U; Kloetzel PM
J Exp Med; 2000 Feb; 191(3):503-14. PubMed ID: 10662796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
